Scynexis (SCYX) Shares Outstanding (Entity) (2013 - 2026)
Scynexis (SCYX) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 834.66 Mn |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | 9.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.95 Mn |
| Mar 31, 2026 | 6.37 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Sep 30, 2025 | 5.24 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 6.06 Mn |
| Sep 30, 2024 | 6.08 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Dec 31, 2023 | 5.98 Mn |
| Sep 30, 2023 | 5.99 Mn |
| Jun 30, 2023 | 5.98 Mn |
| Mar 31, 2023 | 5.97 Mn |
| Dec 31, 2022 | 5.33 Mn |
| Sep 30, 2022 | 5.94 Mn |
| Jun 30, 2022 | 5.41 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Dec 31, 2021 | 3.59 Mn |
| Sep 30, 2021 | 2.99 Mn |